BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1563 related articles for article (PubMed ID: 19697349)

  • 1. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.
    Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM
    Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
    Meissner A; Wernig M; Jaenisch R
    Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
    Aasen T; Raya A; Barrero MJ; Garreta E; Consiglio A; Gonzalez F; Vassena R; Bilić J; Pekarik V; Tiscornia G; Edel M; Boué S; Izpisúa Belmonte JC
    Nat Biotechnol; 2008 Nov; 26(11):1276-84. PubMed ID: 18931654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Induced Pluripotent Stem Cells in Rabbits.
    Afanassieff M; Tapponnier Y; Savatier P
    Methods Mol Biol; 2016; 1357():149-72. PubMed ID: 25413017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.
    Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J
    Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
    Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
    Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
    Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.
    Kaichi S; Hasegawa K; Takaya T; Yokoo N; Mima T; Kawamura T; Morimoto T; Ono K; Baba S; Doi H; Yamanaka S; Nakahata T; Heike T
    Cardiovasc Res; 2010 Nov; 88(2):314-23. PubMed ID: 20547733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.